Serum albumin and self-reported prevalence of stroke: A population-based, cross-sectional study

European Journal of Preventive Cardiology

Volumn 13, Issue 1, 2006, Pages 87-90

  Hýstmark, Arne T ^a   Tomten, Sissel E ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b NORWEGIAN SCHOOL OF SPORT SCIENCES   (Norway)

Author keywords

age; gender; serum albumin; stroke risk

Indexed keywords

SERUM ALBUMIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; CIGARETTE SMOKING; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NERVOUS SYSTEM FUNCTION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SELF REPORT; STROKE;

ADULT; AGE FACTORS; AGED; CEREBROVASCULAR ACCIDENT; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NORWAY; PREVALENCE; RISK FACTORS; SERUM ALBUMIN;

EID: 33646077667     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/01.hjr.0000188245.54287.df     Document Type: Article

References (25)

1. Phillips A, Shaper AG, Winchup PH. Association between serum albumin and mortality fromcardiovascular disease, cancer, and other causes. Lancet 1989; 2: 1434–1436.
2. Shibata H, Haga H, Ueno M, Nagai H, Yasumura S, Koyano W. Longitudinal changes of serum in elderly people living in thecommunity. Age Ageing 1991; 20: 417–420.
3. Herrmann FC, Safran C, Levkoff SE, Minaker KL. Serum albumin level on admission as a predictor of death, lengthof stay, and readmission. Arch Intern Med 1992; 152: 125–130.
4. Agarwal N, Acevedo F, Leighton LS, Cayten CG, Pitchumoni CS. Predictive ability of various nutritional variables for mortalityin elderly people. Am J Clin Nutr 1988; 48: 1173–1178.
5. Corti MC, Guralnik JM, Salive ME, Sorkin JD. Serum albumin level and physical disability as predictors ofmortality in older persons. JAMA 1994; 272: 1036–1042.
6. Aptaker RL, Roth EJ, Reichardt G, Duerden ME, Levy CE. Serum albumin level as a predictor of geriatric strokerehabilitation outcome. Arch Phys Med Rehabil 1994; 75: 80–84.
7. Djousse L, Rothman KJ, Cupples LA, Levy D, Ellison RC. Serum albumin and risk of myocardial infarction and all-causemortality in the Framingham Offspring Study. Circulation 2002; 106: 2919–2924.
8. Høstmark AT. Serum albumin and prevalence of coronary heart disease: apopulation-based, cross sectional study. Nor JEpidemiol 2003; 13: 107–113.
9. Gillum RF, Ingram DD, Makuc DM. Relation between serum albumin concentration and stroke incidenceand death: the NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 1994; 140: 876–878.
10. Belayev L, Liu Y, Zhao W, Busto R, Ginsberg MD. Human albumin therapy of acute ischemic stroke: markedneuroprotective efficacy at moderate doses and with broad therapeuticwindow. Stroke 2001; 32: 553–560.
11. Liu Y, Belayev L, Zhao W, Busto R, Belayev A, Ginsberg MD. Neuroprotective effect of treatment with human albumin inpermanent focal cerebral ischemia: histopathology and cortical perfusionstudies. Eur J Pharmacol 2001; 428: 193–201.
12. Belayev L, Pinard E, Nallet H, Seylaz J, Liu Y, Riyamongkol P, et al. Albumin therapy of transient focalcerebral ischemia: in vivo analysis of dynamic microvascularresponses. Stroke 2002; 33: 1077–1084.
13. Doumas BT, Watson WA, Biggs HG. Albumin standards and the measurement of serum albumin withbromcresol green. Clin Chim Acta 1971; 31: 87–96.
14. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoproteincholesterol in plasma, without use of the preparativeultracentrifuge. Clin Chem 1972; 18: 499–502.
15. Muntner P, Garrett E, Klag MJ, Coresh J. Trends in stroke prevalence between 1973 and 1991 in the USpopulation 25 to 74 years of age. Stroke 2002; 33: 1209–1213.
16. Halliwell B. Albumin: an important extracellularantioxidant? Biochem Pharm 1988; 37: 569–571.
17. Newsholme EA, Leech AR. Biochemistry for the medical sciences Chichester: Wiley; 1983.
18. Oliver MF, Kurien VA, Greenwood TW. Relation between serum free fatty acids and arrhythmias and deathafter acute myocardial infection. Lancet 1968; 1: 710–715.
19. Tansey MJB, Opie LH. Relation between plasma free fatty acids and arrhythmias withinthe first twelve hours of acute myocardial infarction. Lancet 1983; 2: 419–422.
20. Endresen MJ, Lorenzen B, Henriksen T. Increased lipolytic activity and high ratio of free fatty acidsto albumin in sera from women with preeclampsia leads to triglycerideaccumulation in cultured endothelial cells. Am JObstet Gynecol 1992; 167: 440–447.
21. Høstmark AT, Lystad E. Growth inhibition of human hepatoma (HepG2) cells bypolyunsaturated fatty acids. Protection by albumin and vitaminE. Acta Physiol Scand 1992; 144: 83–88.
22. Lystad E, Høstmark AT, Kiserud C, Haugen å. Influence of fatty acids and bovine serum albumin on the growthof human hepatoma and immortalized human kidney epithelialcells. In Vitro Cell Dev Biol 1994; 30A: 568–573.
23. Raz A, Livne A. Differential effects of lipids on the osmotic fragility oferythrocytes. Biochem Biophys Acta 1973; 311: 222–229.
24. Høstmark AT, Lystad E. Lipid peroxidation and growth inhibition of human microvascularendothelial cells. In Vitro Cell Dev Biol 2001; 37: 618–623.
25. Høstmark AT, Stensrød B, Jebens E, Lystad E, Kierulf P, Laake K. Blood reticulocyte count and plasma lactate dehydrogenaseactivity are positively related to the free fatty acid/albuminratio in geriatric patients. Scand J Clin Lab Invest 1995; 55: 649–653.